Your SlideShare is downloading. ×
0
Hematology aplasticanemia-120108092936-phpapp02
Hematology aplasticanemia-120108092936-phpapp02
Hematology aplasticanemia-120108092936-phpapp02
Hematology aplasticanemia-120108092936-phpapp02
Hematology aplasticanemia-120108092936-phpapp02
Hematology aplasticanemia-120108092936-phpapp02
Hematology aplasticanemia-120108092936-phpapp02
Hematology aplasticanemia-120108092936-phpapp02
Hematology aplasticanemia-120108092936-phpapp02
Hematology aplasticanemia-120108092936-phpapp02
Hematology aplasticanemia-120108092936-phpapp02
Hematology aplasticanemia-120108092936-phpapp02
Hematology aplasticanemia-120108092936-phpapp02
Hematology aplasticanemia-120108092936-phpapp02
Hematology aplasticanemia-120108092936-phpapp02
Hematology aplasticanemia-120108092936-phpapp02
Hematology aplasticanemia-120108092936-phpapp02
Hematology aplasticanemia-120108092936-phpapp02
Hematology aplasticanemia-120108092936-phpapp02
Hematology aplasticanemia-120108092936-phpapp02
Hematology aplasticanemia-120108092936-phpapp02
Hematology aplasticanemia-120108092936-phpapp02
Hematology aplasticanemia-120108092936-phpapp02
Hematology aplasticanemia-120108092936-phpapp02
Hematology aplasticanemia-120108092936-phpapp02
Hematology aplasticanemia-120108092936-phpapp02
Hematology aplasticanemia-120108092936-phpapp02
Hematology aplasticanemia-120108092936-phpapp02
Hematology aplasticanemia-120108092936-phpapp02
Hematology aplasticanemia-120108092936-phpapp02
Hematology aplasticanemia-120108092936-phpapp02
Hematology aplasticanemia-120108092936-phpapp02
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Hematology aplasticanemia-120108092936-phpapp02

250

Published on

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
250
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
18
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Aplastic Anemia Dr. Kalpana Malla MD Pediatrics Manipal Teaching HospitalDownload more documents and slide shows on The Medical Post [ www.themedicalpost.net ]
  • 2. PANCYTOPENIA:• Simultaneous presence of anaemia, leukopenia, thrombocytopenia• Causes: aplastic anemia Subleukemic leukemia cytotoxic drugs radiotherapy bone marrow infiltration hypersplenism megaloblastosis SLE
  • 3. APLASTIC ANEMIA:• Failure of two or more cell lines• Anaemia, leukopenia, thrombocytop enia + Hypoplasia or aplasia of the marrow
  • 4. Pathology:• Reduction in the amount of haemopoietic tissue- inability to produce mature cells for discharge into the bloodstream• Patchy areas of normo/hypercellularity betn areas of hypocellularity
  • 5. CLASSIFICATION:• Idiopathic• Secondary: idiosyncratic drug reaction chemical exposure infectious hepatitis paroxysmal nocturnal haemoglobinuria• Constitutional
  • 6. CLASSIFICATIONCONSTITUTIONAL/CONGENITAL• Diamond-Blackfan syndrome• Shwachmann-Diamond syndrome• Fanconi anemia• Dyskeratosis Congenita• TAR (thrombocytopenia with absent radii)• Amegakaryocytic thrombocytopenia
  • 7. FANCONI ANEMIA• Familial• AR• M:F=1.3:1• Onset in 1st decade of life• Diminished capacity for DNA repair and increased random chromosome breakage during mitosis
  • 8. C/F:• Facies – microphthalmia,depressed nasal bridge,epicanthic fold,micrognathia• Hyperpigmentation, café-au-lait spots• Absent / hypoplastic thumb• Skeletal and renal lesions• Short stature,• Microcephaly , subnormal intelligence• Hypogonadism,ano malies of urinary tract• Predisposition to leukemias• Poor prognosis
  • 9. DYSKERATOSIS CONGENITA• X-linked, AR, AD• M:F= 4.3:1• Hyperpigmentation• Nail dystrophy, early loss of teeth• Leukoplakia• Ocular abnormalities: cataract etc• Short stature but No skeletal/renal lesions (diff from FA)
  • 10. DIAMOND BLACKFAN SYNDROME• Congenital pure red cell aplasia• AD, AR, Sporadic• Familial in 15 %• 90 % diagnosed in 1st year of life• Intrinsic defect in RBC, early apoptosis• Macrocytic anemia, reticulocytopenia, absence of RBC precursors in an otherwise normocellular bone marrow
  • 11. DIAMOND BLACKFAN SYNDROME• Eye - Wide set eyes, blue sclera,glaucoma,epicanthic fold,cataract,strabismus• Thick upper,cleft lip palate in some cases• lip,intelligent expression• Upperlimb anomalies – flattening of thenar eminence, Triphalangeal thumb
  • 12. C/F:• Profound anemia at 2-6 months of age• Short stature• Renal anomalies and hypogonadism maybe present
  • 13. ACQUIRED APLASTIC ANEMIA - CAUSES• Radiation • Immune diseases:• Drugs and chemicals - eosinophilic fascitis - chemotherapy - thymoma - benzene • Pregnancy - chloramphenicol • PNH - antiepileptics • Marrow replacement:• Viruses: - leukemia - CMV - myelofibrosis - EBV - myelodysplasia - Hep B, C,D - HIV
  • 14. PATHOPHYSIOLOGY• Direct destruction of haemopoietic progenitors• Disruption of marrow micro-environment• Immune –mediated suppression of marrow elements  Cytotoxic T cells in blood and marrow release gamma IFN and TNF -> inhibit early and late progenitor cells
  • 15. Pathology:• Hallmark: peripheral pancytopenia with hypoplastic/ aplastic bone marrow
  • 16. CLINICAL FEATURESRBC (anemia)• Progressive and persistent pallor• Anemia related symptomsWBC (Leucopenia/neutropenia)• Prone to infections - Pyodermas, OM, pneumonia, UTI, GI infections, sepsisPlatelets (Thrombocytopenia)• Petechiae, purpura, ecchymoses• Hematemesis, hematuria, epistaxis, gingival bleed• IC bleed- headache, irritability, drowsiness, coma
  • 17. NO HEPATOMEGALY NO SPLENOMEGALY NO LYMPHADENOPATHYFailure of entire RES. No extramedullary hematopoesis
  • 18. Blood picture:• Anemia-normocytic, normochromic• Leukopenia (neutropenia)• Relative lymphocytosis• Thrombocytopenia• Absolute reticulocyte count low• Mild to moderate anisopoikilocytosis
  • 19. Other investigations• BM : dry aspirate, hypocellular with fat (>70% yellow marrow)
  • 20. SEVERITYSEVERE APLASTIC ANEMIA• Granulocyte count <500/cu.mm• Platelet count <20,000/cu.mm• Reticulocytes <1%• BM < 25% of hematopoeitic cellsVERY SEVERE/ EXTREME APLASTIC ANEMIA• Above + Granulocyte count <200/cu.mm
  • 21. DIFFERENTIAL DIAGNOSIS• ITP• LEUKEMIA• MYELOID METAPLASIA
  • 22. Management:• Identification and elimination of underlying cause• Supportive therapy:1. Red cell transfusion for anemia2. Prevention and treatment of haemorrhage3. Prevention and treatment of infection
  • 23. SUPPORTIVE CARE• Prophylactic antibiotics• If infection: cephalosporins + aminoglycosides + metronidazole• Antifungals: amphotericin B, fluconazole (if fever >10 days despite antibiotics)
  • 24. THERAPYDEFINITIVE• BONE MARROW TRANSPLANTATION• IMMUNOSUPPRESSION
  • 25. BONE MARROW TRANSPLANTATION• Treatment of choice• HLA matched donor. Usually siblings• Long term survival rates: 60-70%• Donor stem cells > 4 X 108 cells/kg
  • 26. IMMUNOSUPPRESSION• Antithymocyte globulin (ATG)• Antilymphocyte glubulin (ALG)• Cyclosporin• Intensive immunosupression : cyclophosphamide• Corticosteroids
  • 27. ATG administration:• IV administration of Ig preparations containing antibody to human thymocytes• Improvement in haematological indices in one-half of subjects• Anaphylaxis
  • 28. ATG AND ALG• Dose : 40 mg/kg/day X 4 days• Hematologic response rate 45%• Survival rate 60%• Side effects: serum sickness
  • 29. ANDROGENS• No longer have primary role• Increase erythopoietin producion• Stimulate erythroid stem cells• Increase Hb levels in normal males methyl testosterone, testesterone enanthate, oxymetholone, danazolOral dose : 2-5mg/kg/day, IM dose: 1-2mg/kg/wkSide effects: cholestatic jaundice, masculinization
  • 30. Corticosteroids:• High dose steroids combined with anabolic agents• Uncertain benefits• Side-effects
  • 31. HAEMATOPOIETIC GROWTH FACTORS• GM-CSF• G-CSF• IL-3• IL-1• IL-6
  • 32. Thank youDownload more documents and slide shows on The Medical Post [ www.themedicalpost.net ]

×